Archives

CONTENTS

SESSION 1. TOOLS IN THE ANGIOLOGISTS PERIPHERAL ARTERIAL ........ 12
SESSION 2. ADVANCES IN CARDIOVASCULAR CARE ............................ 22
SESSION 2 A. ERECTILE DYSFUNCTION / 2011 NEWS AND THERAPEUTIC ATTITUDES ........ 24
SESSION 3. FACETS OF STATINS 1001 ..............................................30
SESSION 4. CARDIOVASCULAR RISK AND EVALUATION .................................35
SESSION 4 A. VASCULAR KIDNEY FROM A TO Z ......................................................... 38
SESSION 5. READING ....................................................... 39
SESSION 6. SOME ASPECTS OF LOWER LIMB VENOUS REFLUX .............. 41
SESSION 6 BIS. RESEARCH GROUP SESSION OF THE SFA ......................................47
SESSION 7. 1001 FACETS OF ENDOVENOUS LASER  IN 2011 ...........................................54
SESSION 8. SUPERFICIAL VENOUS THROMBOSIS .............................................62
SESSION 8 A. NEWS LYMPHOLOGIE...............................................66
SESSION 9. NEW ANTIPLATELET AND ANTICOAGULANT....................................68
SESSION 9 A. ANGIOLOGY AESTHETIC ...............................................70
TER SESSION 9. NEW APPROACH TO FOOT PLURIDISCIPLIANIRE ..................................... 72
SESSION 10. DEBATE THE COMPRESSION IN VENOUS DISEASE .............................. 73
SESSION 11. VARIS GIS SYMPOSIUM: IN MEDICAL AND PREGNANCY .................... 73
SESSION 12. SITTING OF VASCULAR NETWORK FRENCH SCIENCE ........................ 77
WORKSHOPS ............................................... 82
ACKNOWLEDGMENTS .................................................84
SPEAKERS 'ADDRESSES ........................................85
INDEX ANGIOLOGY 2010 ............................................... 88
AUTHORS 2010 ..............................................91
63ES ANNOUNCES INTERNATIONAL CONFERENCE OF FRANCOPHONE ANGIOLOGY ............ 3
MEMBERSHIP FORM SFA ........................................10
SUBSCRIPTION ..............................................2
ADVERTISERS LIST ...............................................96

CONTENTS

Editorials
The angiologist is there a (good) prescribing? JP BENIGNI and Mr. CAZAUBON ............................ 10
Pelvic congestion syndrome. J. LEAL MONEDERO, E. ZUBICOA, A. LARANA SOLE.................. 13
11th ANNUAL CONGRESS OF THE EUROPEAN VENOUS FORUM (Antwerp, Belgium) M. PERRIN......... 15


Practice Angiology
Support of non-hospital vital distress: What to do while waiting for rescue or assistance of a medical intensive care unit e mobile? B. TOLEDANO, C. VAISLIC, E. MARTINOD et Y. COHEN......................... 16
Health technology assessment: medico-economic analysis on "efficiency and effectiveness of lipid lowering. analysis focused on statins. HAS July 2010»............................24
The CREST study does change really an indication of angioplasty, carotid stenting? C. PETITJEAN ............ 32
Measurement of carotid intima-media thickness in a population of hypertensive Senegalese
a cross-sectional study about 144 cases.M. BAYE A. et al. ................. 36
Recent data on ezetimibe.M. CAZAUBON et R. AZAR......................................... 42


Peripheral arterial surgery
Is it possible to prevent major amputations in diabetic neuropathy? F. LENGUA, A. LA MADRID, J. VARGAS.........................................44


Wound Care
Faced with a sore lower limbs, which diagnoses evoke? F. GLAUSER, M. DEPAIRON........ 52


History of Medicine
Jean-Baptiste Bouillaud (1796-1881) by J.M. MOUTHON.....................................59


Information
Press Releases: Xarelto ®: Press Conference Bayer Health Care June 2010 .......... 62
Comments on "STRIPPING versus the CHIVA method" by P. PITTALUGA ........... 64
ACCOUNT - SUMMARY OF ITEMS AND CONFERENCES .........................................66
XLII CONGRESS OF THE EUROPEAN PHLEBECTOMY LYON (France)
APRIL 2010 - P.L. CHOUKROUN .............................................66
Membership form to the SFA ...........................................12
Announcement of the 63rd International Meeting of Angiology Francophones .................. 3-8
Advertisers list ............................................. 70
Subscriptions .......................................... 71
Instructions to Authors ................................... 72

CONTENTS

Editorials
Turn ride!. Mr. CAZAUBON ......................................... 6


Arteries
Peripheral arterial disease: S-scale CLAU ............... 9
Occlusive arterial disease of lower limbs. Health Authority ............ 12
Revascularization for critical lower limb ischemia - Prospective study about 20 cases in Dakar. P.S BA, A.G. CISS, O. DIARRA, A. NDIAYE, P.A. DIENG, G. CISSE, S.A. BEYE, M. NDIAYE..... 33
CREST syndrome revealed by a pulmonary hypertension: report of a case. M.B. NDIAYE, M. DIAO, M. BODIAN, A.D. KANE, A. MBAYE, F. KARMA, E.C.C. CISS, M. SARR, S.A. BA ........ 41


Cardiovascular Prevention
NaCl and hypertension: what if it was the Cl-Na and not who was responsible. F. A. ALLAERT ......... 45


Venous thromboembolic disease
Interests of the Doppler in the superficial venous thrombosis of the lower M. CAZAUBON, B. ANASTASIE, J.L. GILLET....................................... 48
Support for spontaneous venous thrombosis sharp as sitting at the confluence sapheno femoral or popliteal sapheno: VASCULAB. A.N. NONATO-CASTRO, E. MENDOZA, F. PASSARIELLO, E. RABE..............56
Dabigatran versus warfarin in patients with atrial fibrillation. A. GALA, C. BIRON-ANDREANI............................................65


Veins
Analysis of survey results DECIDES: pragmatic assessment of the properties of a grid for the diagnosis of chronic venous disease in general practice. M. CAZAUBON, J.C. KERIHUEL.................... 68
Sclerotherapy: my method. F. FERRARA...................................82


History of Medicine
1 / The men of exceptional that have advanced cardiovascular medicine.M. RAYNAUD (1834-1881) ........ 87
Membership form to the SFA ..........................................7
Announcement of the 63rd International Meeting of Angiology Francophones ......4-5 and 101-104
Announcement of Conference and events .................................. 90
Press Releases ...............................................95
Advertisers list ...............................................67
Subscriptions ..............................................100
Instructions to Authors .............................................Cover. 3

CONTENTS

Editorials
Acute ischemia and chronic ischemia. Mr. CAZAUBON............................... 5
SFA Report 2009. M. CAZAUBON et F.A. ALLAERT ............................................7


Arteries
Supportive Treatment with CoenzymeQ10 in Heart Failure: the Irvine3 labs in Heart Failure Study on Vascular
Patients.  G. BELCARO, M. R. CESARONE, A. LEDDA, U. CORNELLI, M. DUGALL, S. STUARD,
E. IPPOLITO, M. G. GROSSI, I. RUFFINI .................................................... 9
Resistance to antiplatelet drugs: interest in clinical practice and laboratory tests for primary screening. S. ARMERO, F. PAGANELLI, l. CAMOIN-JAU, l. BONELLO .........................17
Lipid profile and cardiovascular risk of type 2 diabetes in Senegal.A. MBAYE, N.V. YAMEOGO,
Ad. KANE, A. DIACK, M.B. NDIAYE, B. DIACK, S. PESSINABA, A. THIAM, M. DIOUM, R. HAKIM, D. DIAGNE, M. KANE, M. NDOUR, M. DIAO, A. DIALLO, S.N. DIOP, A. KANE............................ 26
Venous arterialization of the foot as against the current treatment of critical limb ischemia. F. LENGUA,
A. LA MADRID, J. VARGAS, C. ACOSTA ................................ 31
Transcranial Doppler and sickle cell disease. S. VERlHAC, S. BAlANDRA ................................ 37


Venous thrombo embolic
Echo-Doppler monitoring after DVT: when, for whom?. F. CHLEIR .................................. 41


Veins
Should we take into account the genetic characteristics of venous ulcers?  M. R. BOISSEAU, M. CAZAUBON............... 43
Neovascularization post-surgery is a fatality? What is the responsibility of the surgeon?. D. CRETON .................... 47


Proceedings of Congress
XLI Meeting of the European Society of Phlebectomy. Bellagio (Italy) - October 10, 2009. P.l. CHOUKROUN ...............................................56


Membership form to the SFA .......................................16
Announcement of Conference and events ......................................60
The new site ........................................62
Index authors and articles 2009............................................ 63
Advertisers list ...............................................71
Subscriptions ..............................................72
Instructions to Authors ............................................... Cover. 3

CONTENTS

FUNCTIONAL EXPLORATIONS SUPRA AORTIC TRUNKS OF VASCULAR .............. 3
CLUSTER HEADACHE FACE AND ANGIOLOGY ..................... 11
NEWS FLASH ....................................................... 15
THE PAD IN DIABETICS ..................................................... 17
HOW SCLEROSIS IN 2010 VARICOSE VEINS? ............................................. 22
ERECTILE DYSFUNCTION (ED) IN 2010 ...................................................... 26
LONG-TERM TREATMENT EMBOLISM AND THROMBOEMBOLIC DISEASE ......................... 31
FOR A REASONED APPROACH FOR SURGICAL TREATMENT OF VENOUS INSUFFICIENCY DEEP IN LEGS .......................... 33
HEALING WOUNDS AND LOWER LIMB / A PATHOLOGY OF AGING? ............................. 38
NEWS ON RADIO FREQUENCY AND ENDOVENOUS LASER ........................... 42
BEAUTY AND ANGIOLOGY ......................................... 46
GIS SYMPOSIUM VARIS COMPRESSION CLASS 3: EXPERTS AND EXPERTISE ....................... 47
PATIENT CARE BY VASCULAR ANGIOLOGISTS........................... 51
FREE COMMUNICATIONS AND SUMMARY OF WORKING GROUPS ......................... 52
WORKSHOP MANAGEMENT OF VENOUS ULCER: COMPRESSION TREATMENT OF WOUND AND WHAT ELSE? ........................ 55
FIRST MEETING OF WORKING AT THE PALACE OF THE LUXEMBOURG ................... 57
SPEAKERS 2010 ................................................. 66

CONTENTS

The angiologist and carotid disease in 2009. M. CAZAUBON, G.A. PELOUZE....................................... 5
When technological advances are pushing the science or consciousness. M. CAZAUBON, G.A. PELOUZE .................................. 7


Roundtable stroke


Carotid stenosis: beyond the light!.J.-L. BERTRAND, G.-A. PELOUZE, J.-M. BÉNÉJEAN........................ 13
Search for thrombophilia in the etiological of arterial ischemic stroke in young patients: the experience of the Centre Hospitalier de Perpignan. G. RUNAVOT, D. SABLOT, M. JOLY, B. FADAT, A. DUTRAY..................23
Fibrinolysis in cerebral ischemia.. SABLOT, Z. KASSEM, G. RUNAVOT, C. NEGRE...................................... 39
What's new in the secondary prevention of cerebral ischemia?. C. LUCAS ........................... 47
Carotid stenting in 2009. B. Beyssen .................................................53
Carotid Doppler ultrasound to identify pre-clinical vascular disease and assess the risk
Cardiovascular. Translated by M. CAZAUBON .............................................57
List of procedures and services long-term illness: stroke.
HAS: Update June 2009 .......................................................... 66


Cardiovascular Prevention


Role of aspirin and statins in primary prevention. M.-C. AUMONT..................................... 83
Should be used statins (rosuvastatin) for primary prevention of cardiovascular disease and venous thromboembolism?. C. BIRON-ANDRÉANI............................................. 85


Erectile Dysfunction


Cardiovascular disease, erectile dysfunction and myeloperoxidase. . ROUMEGUÈRE, P. V. ANTWERPEN,
K. ZOUAOUI BOUDJELTIA, M. VANHAEVERBEEK, E. WESPES .............................. 88


Clinical Cases


Association of femoral pseudoaneurysm and contralateral femoral aneurysm.M. FITOUSSI................... 93


Analysis of articles and books


Travel and Risk for Venous Thromboembolism.  F. CHLEIR .......................... 97
The 10 key points on the heparin-induced thrombocytopenia (HIT). Mr. CAZAUBON ..................... 98
Program JIFA 2010 ..............................................9
Membership form to the SFA ............................................... 84
Advertisers list .......................................................................... 95
Subscriptions ....................................................................... 96
EPP information ..................................................................................... 99
Conference proceedings ............................................................. 100
Announcements of conferences and events ...........................................105
Press Release - XARELTA ® ................................................ 108
Instructions to Authors ..................................................... Cover. 3